0001752724-19-048615.txt : 20190529 0001752724-19-048615.hdr.sgml : 20190529 20190529135744 ACCESSION NUMBER: 0001752724-19-048615 CONFORMED SUBMISSION TYPE: NPORT-EX PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190331 FILED AS OF DATE: 20190529 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AB CAP FUND, INC. CENTRAL INDEX KEY: 0000081443 IRS NUMBER: 132625045 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: NPORT-EX SEC ACT: 1940 Act SEC FILE NUMBER: 811-01716 FILM NUMBER: 19861051 BUSINESS ADDRESS: STREET 1: ALLIANCEBERNSTEIN LP STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 BUSINESS PHONE: 2129691000 MAIL ADDRESS: STREET 1: ALLIANCEBERNSTEIN LP STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCEBERNSTEIN CAP FUND, INC. DATE OF NAME CHANGE: 20110524 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCEBERNSTEIN CAP FUND,INC DATE OF NAME CHANGE: 20040908 FORMER COMPANY: FORMER CONFORMED NAME: ALLIANCEBERNSTEIN SMALL CAP GROWTH FUND INC DATE OF NAME CHANGE: 19931001 0000081443 S000043215 AB Concentrated Growth Fund C000133671 Advisor Class WPSGX C000133672 Class A WPASX C000133673 Class C WPCSX C000133674 Class I WPSIX C000133675 Class K WPSKX C000133676 Class R WPRSX C000133677 Class Z WPSZX ACCESSION NUMBER: 0001752724-19-039586 NPORT-EX 1 NPORT_830317799215250.htm FOR VALIDATION PURPOSES ONLY - [700748.CG]

AB Cap Fund, Inc.

AB Concentrated Growth Fund

Portfolio of Investments

March 31, 2019 (unaudited)

 

Company

   Shares        U.S. $ Value  

COMMON STOCKS - 95.2%

       

Health Care - 26.2%

       

Biotechnology - 4.6%

       

Celgene Corp. (a)

     251,770        $ 23,751,982  
       

 

 

 

Health Care Equipment & Supplies - 10.2%

       

Abbott Laboratories

     525,467          42,005,832  

West Pharmaceutical Services, Inc.

     90,297          9,950,729  
       

 

 

 
          51,956,561  
       

 

 

 

Life Sciences Tools & Services - 6.4%

       

IQVIA Holdings, Inc. (a)

     225,981          32,507,367  
       

 

 

 

Pharmaceuticals - 5.0%

       

Zoetis, Inc.

     253,345          25,504,241  
       

 

 

 
          133,720,151  
       

 

 

 

Information Technology - 23.2%

       

Electronic Equipment, Instruments & Components - 6.6%

       

Amphenol Corp.-Class A

     356,279          33,646,989  
       

 

 

 

IT Services - 8.1%

       

Mastercard, Inc.-Class A

     175,729          41,375,393  
       

 

 

 

Software - 8.5%

       

Microsoft Corp.

     364,482          42,987,007  
       

 

 

 
          118,009,389  
       

 

 

 

Consumer Discretionary - 16.6%

       

Auto Components - 4.4%

       

Aptiv PLC

     278,150          22,110,144  
       

 

 

 

Hotels, Restaurants & Leisure - 3.4%

       

Starbucks Corp.

     234,933          17,464,919  
       

 

 

 

Internet & Direct Marketing Retail - 3.9%

       

Booking Holdings, Inc. (a)

     11,458          19,993,179  
       

 

 

 

Specialty Retail - 4.9%

       

Ulta Salon Cosmetics & Fragrance, Inc. (a)

     71,370          24,888,860  
       

 

 

 
          84,457,102  
       

 

 

 

Industrials - 9.9%

       

Building Products - 4.5%

       

Allegion PLC

     249,968          22,674,597  
       

 

 

 

Commercial Services & Supplies - 0.7%

       

Stericycle, Inc. (a)

     66,048          3,594,332  
       

 

 

 

Professional Services - 4.7%

       

Verisk Analytics, Inc.-Class A

     181,482          24,137,106  
       

 

 

 
          50,406,035  
       

 

 

 

Communication Services - 9.4%

       

Interactive Media & Services - 9.4%

       

Alphabet, Inc.-Class C (a)

     19,985          23,448,600  

Facebook, Inc.-Class A (a)

     148,040          24,676,788  
       

 

 

 
          48,125,388  
       

 

 

 

Company

   Shares        U.S. $ Value  

Materials - 5.2%

       

Chemicals - 5.2%

       

Ecolab, Inc.

     92,846        $ 16,391,033  

International Flavors & Fragrances, Inc.

     77,346          9,961,391  
       

 

 

 
          26,352,424  
       

 

 

 

Financials - 4.7%

       

Capital Markets - 4.7%

       

Charles Schwab Corp. (The)

     564,035          24,118,137  
       

 

 

 

Total Common Stocks
(cost $355,920,043)

          485,188,626  
       

 

 

 

SHORT-TERM INVESTMENTS - 3.2%

       

Investment Companies - 3.2%

       

AB Fixed Income Shares, Inc. - Government Money Market Portfolio-Class AB,
2.38% (b)(c)(d)
(cost $16,145,361)

     16,145,361          16,145,361  
       

 

 

 

Total Investments - 98.4%
(cost $372,065,404) (e)

 

       501,333,987  

Other assets less liabilities - 1.6%

          8,134,889  
       

 

 

 

Net Assets - 100.0%

        $ 509,468,876  
       

 

 

 

 

(a)

Non-income producing security.

(b)

Affiliated investments.

(c)

The rate shown represents the 7-day yield as of period end.

(d)

To obtain a copy of the fund’s shareholder report, please go to the Securities and Exchange Commission’s website at www.sec.gov, or call AB at (800) 227-4618.

(e)

As of March 31, 2019, the cost basis of investment securities owned was substantially identical for both book and tax purposes. Gross unrealized appreciation of investments was $129,393,920 and gross unrealized depreciation of investments was $(125,337), resulting in net unrealized appreciation of $129,268,583.

 

 

Please note: The sector classifications presented herein are based on the Global Industry Classification Standard (GICS) which was developed by Morgan Stanley Capital International and Standard & Poor’s. The components are divided into sector, industry group, and industry sub-indices as classified by the GICS for each of the market capitalization indices in the broad market.

AB Cap Fund, Inc.

AB Concentrated Growth Fund

March 31, 2019 (unaudited)

In accordance with U.S. GAAP regarding fair value measurements, fair value is defined as the price that the Fund would receive to sell an asset or pay to transfer a liability in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a framework for measuring fair value, and a three-level hierarchy for fair value measurements based upon the transparency of inputs to the valuation of an asset or liability (including those valued based on their market values). Inputs may be observable or unobservable and refer broadly to the assumptions that market participants would use in pricing the asset or liability. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability based on market data obtained from sources independent of the Fund. Unobservable inputs reflect the Fund’s own assumptions about the assumptions that market participants would use in pricing the asset or liability based on the best information available in the circumstances. Each investment is assigned a level based upon the observability of the inputs which are significant to the overall valuation. The three-tier hierarchy of inputs is summarized below.

 

   

Level 1—quoted prices in active markets for identical investments

   

Level 2—other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

   

Level 3—significant unobservable inputs (including the Fund’s own assumptions in determining the fair value of investments)

Where readily available market prices or relevant bid prices are not available for certain equity investments, such investments may be valued based on similar publicly traded investments, movements in relevant indices since last available prices or based upon underlying company fundamentals and comparable company data (such as multiples to earnings or other multiples to equity). Where an investment is valued using an observable input, by pricing vendors, such as another publicly traded security, the investment will be classified as Level 2. If management determines that an adjustment is appropriate based on restrictions on resale, illiquidity or uncertainty, and such adjustment is a significant component of the valuation, the investment will be classified as Level 3. An investment will also be classified as Level 3 where management uses company fundamentals and other significant inputs to determine the valuation.

The following table summarizes the valuation of the Fund’s investments by the above fair value hierarchy levels as of March 31, 2019:

 

Investments in Securities:

   Level 1     Level 2     Level 3     Total  

Assets:

 

Common Stocks (a)

   $ 485,188,626     $ – 0  –    $ – 0  –    $ 485,188,626  

Short-Term Investments

     16,145,361       – 0  –      – 0  –      16,145,361  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total Investments in Securities

     501,333,987       – 0  –      – 0  –      501,333,987  

Other Financial Instruments (b)

     – 0  –      – 0  –      – 0  –      – 0  – 
  

 

 

   

 

 

   

 

 

   

 

 

 

Total

   $     501,333,987     $             – 0  –    $             – 0  –    $     501,333,987  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

(a)

See Portfolio of Investments for sector classifications.

(b)

Other financial instruments are derivative instruments, such as futures, forwards and swaps, which are valued at the unrealized appreciation/(depreciation) on the instrument. Other financial instruments may also include swaps with upfront premiums, options written and swaptions written which are valued at market value.

A summary of the Fund’s transactions in AB mutual funds for the nine months ended March 31, 2019 is as follows:

 

Fund

   Market Value
6/30/18
(000)
     Purchases
at Cost
(000)
     Sales
Proceeds
(000)
     Market Value
3/31/19
(000)
     Dividend
Income
(000)
 

Government Money Market Portfolio

   $ 23,239      $ 100,570      $ 107,664      $ 16,145      $ 207